PROGRAM
Toward Elimination of Viral Hepatitis:
Achievements, Challenges, and Prospects
September 21-23, 2023 ㅣ BEXCO, Busan, Korea
08:30-09:50
Pre-Congress Symposium
Youn-Jae Lee (Inje Univ., Korea), Young Oh Kweon (Kyungpook National Univ., Korea), Byung Ik Kim (Sungkyunkwan Univ.)
Updates on Epidemiology and Natural Course of Viral Hepatitis in Asian-Pacific Region: HBV
Jeong Eun Song (Daegu Catholic Univ., Korea)
Updates on Epidemiology and Natural Course of Viral Hepatitis in Asian-Pacific Region: HCV
Nae-Yun Heo (Inje Univ., Korea)
Clinical Impacts of Epidemiological Growth of NAFLD in Asian-Pacific Region
Young Youn Cho (Chung-Ang Univ., Korea)
Cure of Viral Hepatitis: Definition and Sub-Classification
Hyun Young Woo (Pusan National Univ., Korea)
Overview of Barriers to HBV Cure
Eun Young Cho (Wonkwang Univ., Korea)
Overview of Barriers to HCV Cure
Tae-Hee Lee (Konyang Univ., Korea)
Discussion
Opening Ceremony
10:20-10:50
President's Choice Lecture
Si Hyun Bae (The Catholic Univ. of Korea, Korea)
A Bold Plan to Eliminate Liver Disease
W. Ray Kim (Stanford Univ., USA)
10:50-11:50
Symposium 1-1. Hepatitis Elimination by 2030: Where Are We Now?
Diana A. Payawal (Fatima Medical Univ., Philippines), Dong Jin Suh (Daehang Hospital, Korea)
HBV 2023: New Therapeutic Strategies against an Old Foe
Sang Hoon Ahn (Yonsei Univ., Korea)
HCV 2023: The Road to Elimination of HCV
Yasuhito Tanaka (Kumamoto Univ., Japan)
Optimizing Hepatitis B and C Treatment in Resource-Limited Settings
Diana A. Payawal (Fatima Medical Univ., Philippines)
Global Care Cascade for Chronic Hepatitis B and C Virus Infection
Ming-Lung Yu (National Sun Yat-sen Univ., Taiwan)
Luncheon Symposium [Abbvie] AGENDA
12:50-13:20
State-of-the-Art Lecture I
Masao Omata (The Univ. of Tokyo, Japan)
A 30-Year Journey of HCV Research: From Discovery to a Cure
Raymond T. Chung (Harvard Univ., USA)
13:20-14:20
Keynote Lecture 1. Viral Hepatitis Elimination: Where Do We Stand? It Has Already Reached Halfway by 2030
Chun-Jen Liu (National Taiwan Univ., Taiwan), Kwang Cheol Koh (Sungkyunkwan Univ., Korea)
Notable Milestones Achieved Towards Viral Hepatitis Elimination to Date
Jose D. Sollano (The Univ. of Santo Tomas, Philippines)
Efforts and Strategy to Accelerate Progress Toward Viral Hepatitis Elimination by 2030
Jinlin Hou (Southern Medical Univ., China)
It Is Time for a Simplified Approach to Hepatitis B Elimination
Young-Suk Lim (Univ. of Ulsan, Korea)
Coffee Break
14:40-16:00
PG Course 1. On the Way to HBV Elimination, What Is a Recent Issue?
Marc G. Ghany (NIH, USA), George Lau (Humanity and Health Medical Group, Hong Kong), Kwang-Hyub Han (CHA Univ., Korea)
When to Stop Nucleos(t)ide Analogues: Risks and Benefits
Jordan Feld (Univ. of Toronto, Canada)
Application of Current Biomarkers to Guide Anti-HBV Treatment
Tetsuya Hosaka (Toranomon Hospital, Japan)
Can Antivirals Reduce Intrahepatic cccDNA and Integrated HBV DNA?
Marc G. Ghany (NIH, USA)
Risk of HCC and Biomarkers after a Cure of Hepatitis B
Jeong Won Jang (The Catholic Univ. of Korea, Korea)
Coffee Break
16:20-17:40
PG Course 2. Treatment of Viral Hepatitis, What Progress Being Made?
Raymond T. Chung (Harvard Univ., USA), Ming-Lung Yu (National Sun Yat-sen Univ., Taiwan), Jin Mo Yang (The Catholic Univ. of Korea, Korea)
Current Optimal Treatment for Chronic HCV Infection in Various Clinical Situations
Jung Il Lee (Yonsei Univ., Korea)
Strategies for the Elimination of HCV Infection
Norah Terrault (Univ. of Southern California, USA)
Current and Emerging Therapeutic Approaches to Hepatitis C
Maria Buti Ferret (Hospital Universitario Valle Hebron, Spain)
HBV-HCV Dual Infection: Changing Epidemiology and Treatment in Asia
Chun-Jen Liu (National Taiwan Univ., Taiwan)
10:50-11:50
Joint Symposium (East Asia): HCV Elimination
Lai Wei (Tsinghua Univ., China), Masao Omata (The Univ. of Tokyo, Japan), Sook-Hyang Jeong (Seoul National Univ., Korea)
Cost-Effectiveness of HCV Screening in Korea: A Step Toward HCV Elimination
Sook-Hyang Jeong (Seoul National Univ., Korea)
Clinical Challenges in HCV Management in Japan
Atsumasa Komori (Nagasaki Univ., Japan)
How Would China Achieve WHO's Target of Eliminating by 2030?
Lai Wei (Tsinghua Univ., China)
Linkage-to-Care and Follow-Up Strategy for HCV Infection in Taiwan
Tai-Chung Tseng (National Taiwan Univ., Taiwan)
Discussion
Luncheon Symposium [Roche] AGENDA
Coffee Break
14:40-16:00
Symposium 1-2. Immunology and Immunotherapy of Viral Hepatitis
Hideki Ueno (Kyoto Univ., Japan), Eui-Cheol Shin (KAIST, Korea)
Immunological Profile of Chronic HBV Infection: Can It Help to Improve Therapeutic Success?
Antonio Bertoletti (Duke-NUS Medical School, Singapore)
Immunological Scar after HCV Clearance
Eui-Cheol Shin (KAIST, Korea)
T-Cell Responses against Hepatitis Viruses in Human Liver
Hideki Ueno (Kyoto Univ., Japan)
Novel Immunological Therapeutics for Cure of HBV Infection
Wonseok Kang (Sungkyunkwan Univ., Korea)
Coffee Break
16:20-17:40
Symposium 1-3. Emerging Antivirals for HBV Cure
Jidong Jia (Capital Medical Univ., China), Seong Gyu Hwang (CHA Univ., Korea)
Updates on Drugs for HBV Entry and Post-Entry Inhibition
Hyung Joon Yim (Korea Univ., Korea)
Updates on HBV Capsid Assembly Inhibitors
Robert G. Gish (Hepatitis B Foundation, USA)
Updates on Drugs Targeting HBV RNAs: ASOs and siRNA
Jidong Jia (Capital Medical Univ., China)
Updates on cccDNA Disruptors
Jin-Wook Kim (Seoul National Univ., Korea)
Luncheon Symposium [Celltrion] AGENDA
13:20-14:20
SIG 1. Diagnostic and Therapeutic Targets for Virus-Associated HCC
Chul Ju Han (Korea Cancer Center Hospital, Korea), Won Young Tak (Kyungpook National Univ., Korea)
Novel Blood-Based Biomarkers for Diagnosis of HCC in Chronic Viral Hepatitis
Jaeyoun Cheong (Ajou Univ., Korea)
TERT Alterations in Virus-Induced Hepatocarcinogenesis: An Actionable Target?
Ju Hyun Shim (Univ. of Ulsan, Korea)
Molecular Signature and Immune Landscape of among HBV, HCV, and Non-Viral HCCs
Young-Sun Lee (Korea Univ., Korea)
Differential T-Cell Function between Viral and Non-Viral HCC during Immuno-Oncologic Therapy
Ji Won Han (The Catholic Univ. of Korea, Korea)
Coffee Break
16:20-17:40
Policy Session (*K)
Young-Suk Lim (Univ. of Ulsan, Korea), Jae Young Jang (Soonchunhyang Univ., Korea)
Introduction of the 1st National Strategic Plan for Viral Hepatitis B & C Control (2023-2027)
Jin Seon Yang (Korea Disease Control and Prevention Agency, Korea)
Hepatitis B & C Elimination Strategy in Korea
Chang Hun Lee (Jeonbuk National Univ., Korea)
Korean HCV Cohort Study and People Who Inject Drugs (PWID) in Korea
Gwang Hyeon Choi (Seoul National Univ., Korea)
Korean HBV Cohort Study
Jun Yong Park (Yonsei Univ., Korea)
Panel Discussion
Speakers & Panelists: In Hee Kim (Jeonbuk National Univ., Korea), Young Chang (Soonchunhyang Univ., Korea)